This meeting will serve as a valuable forum for the presentation and discussion of newly available data from ongoing clinical trials. Participants will be provided with an update on practice-changing data in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients with gynecologic malignancies.
 
The interactive format of the Congress incorporates typical didactic presentations with a significant number of interactive clinical case discussions. Attendees will have the opportunity to respond to integrated clinical cases and debates through the use of an electronic audience response system.

This congress is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners including allied health professionals, involved in the diagnosis and management of gynecologic cancers. 

After successfully completing this educational program, participants should be able to:

• Assess the impact of human papilloma virus (HPV) vaccines on the screening and prevention of cervical cancer
• Develop a practical approach to cervical cancer staging and management of recurrent disease
• Discuss the role of surgery and adjuvant radiotherapy in endometrial cancer
• Describe the use of systemic therapies in recurrent endometrial cancer
• Derive the optimal surgical management of ovarian cancer based on disease stage and clinical presentation
• Identify emerging therapies for ovarian cancer and discuss their progress in clinical development
• Formulate optimal management strategies for recurrent ovarian cancer
• Identify characteristics of uterine sarcomas and discuss the challenges involved in the management of these malignancies
• Provide evidence based recommendations for the management of gynecologic malignancies during pregnancy
• Describe current approaches to the management of ovarian germ cell tumors

Friday - 26 June, 2009
11:30			Registration and Lunch
13:00			Welcome and Introduction
			Session I: Cervical Cancer
13:10			Contemporary approaches in cervical cancer screening and prevention
13:40			Best practices in staging of cervical cancer
14:10			Interactive clinical case: Recurrent squamous carcinoma of the cervix
14:40			Break
			Session II: Ovarian Cancer I: Surgery and First-Line Therapy
15:10			State of the art surgical strategies in ovarian cancer
15:40			Expanding options in the first-line setting
			Session III: Keynote Lecture
16:10			Changing standards of care: Recent advances in the management of recurrent ovarian cancer
17:00			Adjourn
17:30			Reception
Saturday - 27 June, 2009
7:30			Breakfast
9:00			Welcome and Introduction
			Session IV: Endometrial Cancer
9:05			The role of surgery and adjuvant radiotherapy in endometrial carcinoma
9:35			Interactive clinical case: Systemic therapy for recurrent endometrial cancer
10:05			Break
			Session V: Ovarian Cancer II: Recurrence
10:35			Interactive clinical case: Management of platinum sensitive ovarian cancer
11:05			Debate: Management of a partially platinum sensitive relapse (6-12 months) of epithelial ovarian cancer should involve platinum based combination chemotherapy
11:45			Interactive clinical case: Management of platinum resistant/refractory ovarian
12:15			Lunch
			Session VI: Keynote Lecture
13:30			Emerging options in targeted therapy for ovarian cancer: Anti‐angiogenesis and beyond
			Session VII: Additional Complex Topics in Gynecologic Oncology
14:15			Considerations for gynecologic oncology during pregnancy
14:45			Uterine sarcomas: Characteristics and management
15:15			Concluding remarks
15:30			Adjourn